RYAN LAHEY: Open Payments
NPI 1780242032 · ELLSWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 46 payments from 16 companies in 2025. Trend: 2023 $904 · 2024 $833 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $141 |
| Sumitomo Pharma America, Inc. | 6 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $92 |
| Novartis Pharmaceuticals Corporation | 5 | $86 |
| ABBVIE INC. | 4 | $69 |
| Novo Nordisk Inc | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Amgen Inc. | 2 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: GEMTESA, CAPLYTA, LEQVIO, NURTEC ODT, VRAYLAR, PREVNAR 20, AIRSUPRA, Auvelity.
Industry payments across KS — which companies pay providers there.
